Stocks and InvestingStocks and Investing
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $262 on, Oct 23rd, 2019


Published on 2024-10-26 17:13:51 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $212 to $262 on, Oct 23rd, 2019.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019